Phase Ib Study Of Bi 836880 (Vegf/Ang2 Nanobody (R)) Plus Ezabenlimab (Bi 754091, Anti-Pd-1 Antibody) In Patients With Solid TumorsNicolas Girard,Martin Wermke,Fabrice Barlesi,Dong-Wan Kim,Francois Ghiringhelli,Jaafar Bennouna,Thierry Lesimple,Enriqueta Felip,David Berz,Jong-Seok Lee,Harald Timotheus Landsteiner,Victoria Chen,Girish Jayadeva,Jurgen Alt,Bjorn HackansonANNALS OF ONCOLOGY（2021）引用 1|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
